These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19372254)

  • 41. Risk factors for vascular complications and treatment patterns at diagnosis of 2389 PV and ET patients: Real-world data from the Swedish MPN Registry.
    Abdulkarim K; Samuelsson J; Johansson P; Andréasson B
    Eur J Haematol; 2017 Jun; 98(6):577-583. PubMed ID: 28251679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis.
    Alvarez-Larrán A; Pereira A; Magaz M; Hernández-Boluda JC; Garrote M; Cuevas B; Ferrer-Marín F; Gómez-Casares MT; García-Gutiérrez V; Mata-Vázquez MI; Turon F; Hernandez-Gea V; Arellano-Rodrigo E; Cervantes F; García-Pagán JC;
    Ann Hematol; 2020 Apr; 99(4):791-798. PubMed ID: 32086587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
    Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
    Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.
    Ruggeri M; Rodeghiero F; Tosetto A; Castaman G; Scognamiglio F; Finazzi G; Delaini F; Micò C; Vannucchi AM; Antonioli E; De Stefano V; Za T; Gugliotta L; Tieghi A; Mazzucconi MG; Santoro C; Barbui T;
    Blood; 2008 Jan; 111(2):666-71. PubMed ID: 17909074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.
    Gisslinger H; Müllner M; Pabinger I; Heis-Vahidi-Fard N; Gisslinger B; Brichta A; Bachleitner-Hofmann T; Mannhalter C
    Haematologica; 2005 Mar; 90(3):408-10. PubMed ID: 15749677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera.
    Karakantza M; Giannakoulas NC; Zikos P; Sakellaropoulos G; Kouraklis A; Aktypi A; Metallinos IC; Theodori E; Zoumbos NC; Maniatis A
    Int J Hematol; 2004 Apr; 79(3):253-9. PubMed ID: 15168594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex and age as prognostic factors in essential thrombocythemia.
    Randi ML; Fabris F; Rossi C; Tison T; Barbone E; Girolami A
    Haematologica; 1992; 77(5):402-4. PubMed ID: 1483589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.
    Passamonti F; Rumi E; Pungolino E; Malabarba L; Bertazzoni P; Valentini M; Orlandi E; Arcaini L; Brusamolino E; Pascutto C; Cazzola M; Morra E; Lazzarino M
    Am J Med; 2004 Nov; 117(10):755-61. PubMed ID: 15541325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.
    Podoltsev NA; Wang R; Shallis RM; Stempel JM; Di M; Neparidze N; Zeidan AM; Huntington SF; Giri S; Hull SC; Gore SD; Ma X
    Cancer Med; 2023 Sep; 12(18):18889-18900. PubMed ID: 37702132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera.
    Mehtap O; Ateşoğlu EB; Tarkun P; Gönüllü E; Keski H; Topçu Y; Uzülmez N; Sünnetçi D; Hacıhanefioğlu A
    Turk J Haematol; 2012 Jun; 29(2):162-9. PubMed ID: 24744648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia.
    Gangaraju R; Song J; Kim SJ; Tashi T; Reeves BN; Sundar KM; Thiagarajan P; Prchal JT
    Blood Adv; 2020 Mar; 4(6):1115-1130. PubMed ID: 32203583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.
    Carobbio A; Thiele J; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Randi ML; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Finazzi G; Gangat N; Tefferi A; Barbui T
    Blood; 2011 Jun; 117(22):5857-9. PubMed ID: 21490340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombotic complications of polycythemia vera.
    Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
    Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia.
    Grenier JMP; El Nemer W; De Grandis M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):63-69. PubMed ID: 31865003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
    Passamonti F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S25-7. PubMed ID: 22035744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.